Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1516-1522

Spandidos Publications

Access to resources Recommend Favorite

The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation

By Imai Yasuo   Yoshimori Mayumi   Fukuda Kazunori   Yamagishi Hidetsugu   Ueda Yoshihiko  

Oncology Reports, Vol. 27, Iss. 6, 2012-06 ,pp. : 1703-1709

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-31 Inhibits Lung Adenocarcinoma Stem-Like Cells via Down-Regulation of MET-PI3K-Akt Signaling Pathway

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 501-518

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus

By              

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1581-1588

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma

By                    

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1105-1112

Spandidos Publications

Access to resources Recommend Favorite